Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage
BACKGROUND: Russia has one of the highest rates of mortality from cardiovascular disease (CVD). At age 35–69 years, they are eight times higher than in neighbouring Norway. Comparing profiles of blood-based CVD biomarkers between these two populations can help identify reasons for this substantial d...
Published in: | Journal of Epidemiology and Community Health |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Text |
Language: | English |
Published: |
BMJ Publishing Group
2020
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577103/ http://www.ncbi.nlm.nih.gov/pubmed/32414935 https://doi.org/10.1136/jech-2020-213885 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:7577103 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:7577103 2023-05-15T18:34:18+02:00 Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage lakunchykova, Olena Averina, Maria Wilsgaard, Tom Watkins, Hugh Malyutina, Sofia Ragino, Yulia Keogh, Ruth H Kudryavtsev, Alexander V Govorun, Vadim Cook, Sarah Schirmer, Henrik Eggen, Anne Elise Hopstock, Laila Arnesdatter Leon, David A 2020-09 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577103/ http://www.ncbi.nlm.nih.gov/pubmed/32414935 https://doi.org/10.1136/jech-2020-213885 en eng BMJ Publishing Group http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577103/ http://www.ncbi.nlm.nih.gov/pubmed/32414935 http://dx.doi.org/10.1136/jech-2020-213885 © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. CC-BY J Epidemiol Community Health Original Research Text 2020 ftpubmed https://doi.org/10.1136/jech-2020-213885 2020-11-01T01:41:40Z BACKGROUND: Russia has one of the highest rates of mortality from cardiovascular disease (CVD). At age 35–69 years, they are eight times higher than in neighbouring Norway. Comparing profiles of blood-based CVD biomarkers between these two populations can help identify reasons for this substantial difference in risk. METHODS: We compared age-standardised mean levels of CVD biomarkers for men and women aged 40–69 years measured in two cross-sectional population-based studies: Know Your Heart (KYH) (Russia, 2015–2018; n=4046) and the seventh wave of the Tromsø Study (Tromsø 7) (Norway, 2015–2018; n=17 646). A laboratory calibration study was performed to account for inter-laboratory differences. RESULTS: Levels of total, low-density lipoprotein-, high-density lipoprotein-cholesterol and triglycerides were comparable in KYH and Tromsø 7 studies. N-terminal pro-b-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity C-reactive protein (hsCRP) were higher in KYH compared with Tromsø 7 (NT-proBNP was higher by 54.1% (95% CI 41.5% to 67.8%) in men and by 30.8% (95% CI 22.9% to 39.2%) in women; hs-cTnT—by 42.4% (95% CI 36.1% to 49.0%) in men and by 68.1% (95% CI 62.4% to 73.9%) in women; hsCRP—by 33.3% (95% CI 26.1% to 40.8%) in men and by 35.6% (95% CI 29.0% to 42.6%) in women). Exclusion of participants with pre-existing coronary heart disease (279 men and 282 women) had no substantive effect. CONCLUSIONS: Differences in cholesterol fractions cannot explain the difference in CVD mortality rate between Russia and Norway. A non-ischemic pathway to the cardiac damage reflected by raised NT-proBNP and hs-cTnT is likely to contribute to high CVD mortality in Russia. Text Tromsø PubMed Central (PMC) Norway Tromsø Journal of Epidemiology and Community Health jech-2020-213885 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Original Research |
spellingShingle |
Original Research lakunchykova, Olena Averina, Maria Wilsgaard, Tom Watkins, Hugh Malyutina, Sofia Ragino, Yulia Keogh, Ruth H Kudryavtsev, Alexander V Govorun, Vadim Cook, Sarah Schirmer, Henrik Eggen, Anne Elise Hopstock, Laila Arnesdatter Leon, David A Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage |
topic_facet |
Original Research |
description |
BACKGROUND: Russia has one of the highest rates of mortality from cardiovascular disease (CVD). At age 35–69 years, they are eight times higher than in neighbouring Norway. Comparing profiles of blood-based CVD biomarkers between these two populations can help identify reasons for this substantial difference in risk. METHODS: We compared age-standardised mean levels of CVD biomarkers for men and women aged 40–69 years measured in two cross-sectional population-based studies: Know Your Heart (KYH) (Russia, 2015–2018; n=4046) and the seventh wave of the Tromsø Study (Tromsø 7) (Norway, 2015–2018; n=17 646). A laboratory calibration study was performed to account for inter-laboratory differences. RESULTS: Levels of total, low-density lipoprotein-, high-density lipoprotein-cholesterol and triglycerides were comparable in KYH and Tromsø 7 studies. N-terminal pro-b-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity C-reactive protein (hsCRP) were higher in KYH compared with Tromsø 7 (NT-proBNP was higher by 54.1% (95% CI 41.5% to 67.8%) in men and by 30.8% (95% CI 22.9% to 39.2%) in women; hs-cTnT—by 42.4% (95% CI 36.1% to 49.0%) in men and by 68.1% (95% CI 62.4% to 73.9%) in women; hsCRP—by 33.3% (95% CI 26.1% to 40.8%) in men and by 35.6% (95% CI 29.0% to 42.6%) in women). Exclusion of participants with pre-existing coronary heart disease (279 men and 282 women) had no substantive effect. CONCLUSIONS: Differences in cholesterol fractions cannot explain the difference in CVD mortality rate between Russia and Norway. A non-ischemic pathway to the cardiac damage reflected by raised NT-proBNP and hs-cTnT is likely to contribute to high CVD mortality in Russia. |
format |
Text |
author |
lakunchykova, Olena Averina, Maria Wilsgaard, Tom Watkins, Hugh Malyutina, Sofia Ragino, Yulia Keogh, Ruth H Kudryavtsev, Alexander V Govorun, Vadim Cook, Sarah Schirmer, Henrik Eggen, Anne Elise Hopstock, Laila Arnesdatter Leon, David A |
author_facet |
lakunchykova, Olena Averina, Maria Wilsgaard, Tom Watkins, Hugh Malyutina, Sofia Ragino, Yulia Keogh, Ruth H Kudryavtsev, Alexander V Govorun, Vadim Cook, Sarah Schirmer, Henrik Eggen, Anne Elise Hopstock, Laila Arnesdatter Leon, David A |
author_sort |
lakunchykova, Olena |
title |
Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage |
title_short |
Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage |
title_full |
Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage |
title_fullStr |
Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage |
title_full_unstemmed |
Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage |
title_sort |
why does russia have such high cardiovascular mortality rates? comparisons of blood-based biomarkers with norway implicate non-ischaemic cardiac damage |
publisher |
BMJ Publishing Group |
publishDate |
2020 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577103/ http://www.ncbi.nlm.nih.gov/pubmed/32414935 https://doi.org/10.1136/jech-2020-213885 |
geographic |
Norway Tromsø |
geographic_facet |
Norway Tromsø |
genre |
Tromsø |
genre_facet |
Tromsø |
op_source |
J Epidemiol Community Health |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577103/ http://www.ncbi.nlm.nih.gov/pubmed/32414935 http://dx.doi.org/10.1136/jech-2020-213885 |
op_rights |
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.1136/jech-2020-213885 |
container_title |
Journal of Epidemiology and Community Health |
container_start_page |
jech-2020-213885 |
_version_ |
1766219000656691200 |